Article Details

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Research Coverage Started at StockNews.com

Retrieved on: 2023-11-24 14:31:57

Tags for this article:

Click the tags to see associated articles and topics

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Research Coverage Started at StockNews.com. View article details on hiswai:

Excerpt

Schonfeld Strategic Advisors LLC now owns 770,400 shares of the biotechnology company's stock valued at $514,000 after purchasing an additional ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo